- Retraction Note
- Open Access
- Published:
Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation
Stem Cell Research & Therapy volume 13, Article number: 497 (2022)
Retraction Note to: Stem Cell Research & Therapy (2021) 12:449 https://doi.org/10.1186/s13287-021-02371-0
The Editors-in-Chief have retracted this article because there are regions of overlap between Fig. 2A and Fig. 4A. The Editors-in-Chief therefore no longer have confidence in the data presented.
Li Chen does not agree to this retraction. None of the other authors has responded to any correspondence from the publisher about this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
He, Q., Song, J., Cui, C. et al. Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation. Stem Cell Res Ther 13, 497 (2022). https://doi.org/10.1186/s13287-022-03184-5
Published:
DOI: https://doi.org/10.1186/s13287-022-03184-5